Patents Assigned to SAHLTECH I GOTEBORG
  • Publication number: 20110059099
    Abstract: The present invention pertains to the treatment of idiopathic thrombocytopenic purpura (ITP) employing pharmaceutical compositions containing a VLA-4 antagonist as active ingredient. The VLA-4 antagonists may be in form of chemical compounds or antibodies specifically blocking VLA-4 activity avoiding side-effects.
    Type: Application
    Filed: February 3, 2009
    Publication date: March 10, 2011
    Applicant: SAHLTECH I GĂ•TEBORG AB
    Inventors: Hans Wadenvik, Bob Olsson
  • Publication number: 20080221019
    Abstract: The present invention relates to the field of myopathy and particularly to the treatment and/or prevention of inclusion body myositis (IBM). A composition is provided, which comprises as an active ingredient either growth hormone, a secretagogue thereof or a mixture thereof, to cure IBM or suppress the symptoms associated therewith.
    Type: Application
    Filed: April 24, 2006
    Publication date: September 11, 2008
    Applicant: SAHLTECH I GOTEBORG
    Inventors: Lars Olbe, Thord Rosen